Why Novavax Stock Is Soaring Today
Shares of the clinical-stage biotech Novavax (NASDAQ: NVAX) are up by 10.65% as of 10:34 a.m. EDT today. The biotech's shares have now rallied by an astounding 80.7% this week. The spark?
Novavax's shares have been bolting higher of late in response to a newly released clinical update for the company's experimental respiratory syncytial virus (RSV) vaccine known as ResVax. Specifically, the company reported that a new analysis revealed that infants immunized while still in the womb with ResVax exhibited a 56.9% reduction in the incidence rate of pneumonia over the first year of life. The analysis in question was presented at the 2019 IDSOG Annual Meeting held in Big Sky, Montana.
Image Source: Getty Images.
Source Fool.com
